Analyze Diet

Topic:Insulin

Insulin is a hormone produced by the pancreas that plays a pivotal role in regulating glucose metabolism in horses. It facilitates the uptake of glucose by cells, thus maintaining blood sugar levels within a normal range. Insulin's function is integral to energy balance and metabolic processes in equines. Disruptions in insulin regulation can lead to metabolic disorders such as Equine Metabolic Syndrome (EMS), characterized by insulin resistance and associated with obesity and laminitis. This page aggregates peer-reviewed research studies and scholarly articles that explore the physiological role, regulatory mechanisms, and clinical implications of insulin in equine health and disease management.
Temporal variation in incretin and insulin secretion in ponies in association with dietary macronutrients.
Veterinary journal (London, England : 1997)    March 11, 2026   Volume 317 106644 doi: 10.1016/j.tvjl.2026.106644
Andrews KE, Sibthorpe PEM, Fitzgerald DM, de Laat MA.Equine insulin dysregulation (ID) is a common condition that predisposes to hyperinsulinaemia-associated laminitis. Improved pathophysiological understanding would enable better management of ID and reduce the risk of laminitis. The incretin peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), augment the insulin response to dietary glucose and GLP-1 has been implicated in the pathophysiology of ID. However, their temporal variation in response to a low-energy diet has not been reported. This study determined the variation in GLP-1, GIP and insulin ...
Assessment of baseline adrenocorticotropic hormone and insulin concentrations in healthy horses in Saskatchewan over a 1-year period.
Journal of veterinary internal medicine    February 26, 2026   Volume 40, Issue 1 aalaf056 doi: 10.1093/jvimsj/aalaf056
Viviani P, Ragno VM, Parker S, Montgomery JB.Endocrine disorders in horses, such as pituitary pars intermedia dysfunction and equine metabolic syndrome, rely on hormone testing for diagnosis, but seasonal and regional variabilities highlight the need for locally generated data. Objective: To characterize monthly blood concentrations of ACTH and insulin over 1 year in healthy horses in Saskatchewan. A secondary objective was to assess the association between these outcomes and the following factors: sex, age, breed, pregnancy status, level of exercise, body condition score, and cresty neck score. Methods: Sixty-eight clinically healthy, c...
The Effect of Lipemia on Insulin and Adiponectin Measurement in Equine Blood Samples.
Veterinary clinical pathology    February 16, 2026   doi: 10.1111/vcp.70100
Hallowell KL, van Eps AW, Kulp JC, Schnabel LV.Lipemia is a common comorbidity in horses with obesity or equine metabolic syndrome, but the impact of lipemia on the measurement of insulin and adiponectin has not been evaluated. Objective: To evaluate endogenous and exogenous lipemic interference with equine insulin and adiponectin measurements via several commercial assays. Methods: Endogenous lipemia was evaluated using plasma and serum samples with triglyceride concentrations of  1000 mg/dL (n = 6 each). Sample insulin concentrations were determined via fluorescence enzyme immunoassay (FEIA), ELISA, and lateral flow assay (LFA). ...
Blood and fecal metabolic responses of mature horses fed rhizoma peanut hay.
Journal of equine veterinary science    February 11, 2026   Volume 159 105805 doi: 10.1016/j.jevs.2026.105805
Vasco ACCM, Warren LK, Silva GM, Cuervo-Vivas W, Brandi RA, Silva VP, Lance JM, Dubeux JC, Wickens CL.Rhizoma peanut (RP, Arachis glabrata Benth) is an alternative legume forage to alfalfa (ALF, Medicago sativa L.) with less non-structural carbohydrates and crude protein. Yet, metabolic responses to consuming RP hay have never been evaluated in horses. Objective: The objective of this study was to investigate the effect of feeding RP 'Florigraze' hay on fecal and blood metabolic variables compared to alfalfa 'Legendary XHD' and bermudagrass (BMG, Cynodon dactylon L. 'Coastal') hays fed to maintenance horses. Methods: Six mature Quarter Horse geldings (596±40 kg) were randomly assigned to one ...
Differential profiles of GH, IGF-1, and fructosamine in follicular fluid and plasma of cyclic mares.
Domestic animal endocrinology    February 6, 2026   Volume 95 107000 doi: 10.1016/j.domaniend.2026.107000
Satué K, Fazio E, Velasco-Martínez MG, Barbiera G, La Fauci D.Growth hormone (GH) influences follicular development mainly by stimulating insulin-like growth factor 1 (IGF-1), which acts systemically and locally within the ovary. However, the metabolic profile of follicular fluid (FF) in mares, particularly markers such as fructosamine (FRUCT), an indicator of glucose metabolism, remains poorly characterized. This study aimed to evaluate GH, IGF-1, and FRUCT concentrations in plasma and FF and their variation across follicle sizes. Sixty ovaries were collected during the breeding season from 30 clinically normal mares raised for meat production. Blood sa...
Pancreatic islet remodeling in horses with hyperinsulinemia and pituitary dysfunction.
Domestic animal endocrinology    February 4, 2026   Volume 95 106998 doi: 10.1016/j.domaniend.2026.106998
Teague P, Dark M, Verdugo D, Freeman D, McFarlane D.The equine pancreas remains understudied, particularly in the context of endocrine disease. This study aimed to characterize regional islet distribution and composition in the normal equine pancreas and investigate how hyperinsulinemia (HI) and pituitary pars intermedia dysfunction (PPID) influence pancreatic islet morphology and hormone expression. In the first experiment, pancreas samples from eight healthy horses were collected and analyzed across three anatomical locations: left lobe, body, and right lobe. The left lobe exhibited a greater relative islet area and perimeter compared to the ...
Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra-articular triamcinolone acetonide.
Equine veterinary journal    February 1, 2026   doi: 10.1002/evj.70150
Page AE, McPeek JL, McGreevy E, Carattini S, Adam EN.Intra-articular (IA) corticosteroids can cause hyperinsulinemia, which can subsequently increase the risk of laminitis, particularly in horses with insulin dysregulation (ID). Sodium glucose cotransporter 2 inhibitors (SGLT2i), a drug class that is being utilised more commonly in horses with insulin dysregulation, could potentially be used to control post-IA corticosteroid hyperinsulinemia. Objective: To determine whether treatment with the SGLT2i drug ertugliflozin decreases hyperinsulinemia following intra-articular corticosteroid administration in metabolically normal horses. Methods: Prosp...
Case Report: Inhaled salbutamol in the successful treatment of life-threatening acute hyperkalaemia in an anaesthetised horse.
Frontiers in veterinary science    January 16, 2026   Volume 12 1663681 doi: 10.3389/fvets.2025.1663681
Rollet M, Flyps J, Vernemmen I, van Loon G, Schauvliege S.Hyperkalaemia is an uncommon complication of general anaesthesia in healthy horses. This case report describes the occurrence of life-threatening acute hyperkalaemia in a 13-year-old, female French Trotter anaesthetised for experimental right and left atrial 3D electro-anatomical mapping. Intra-operative development of hyperkalaemia (7.55 mmol/L) (Ref. 3.00-4.00 mmol/L) with atrial standstill on ECG necessitated transvenous ventricular pacing while initial treatment with insulin and glucose was initiated. Plasma potassium levels continued to increase (8.00 mmol/L) prompting adjunctive tr...
The Effect of Seasonal Changes in Non-Structural Carbohydrates in Pasture on the Metabolic Profile of Horses with Laminitis.
Animals : an open access journal from MDPI    January 15, 2026   Volume 16, Issue 2 267 doi: 10.3390/ani16020267
Mlyneková E, Zaťko S, Halo M, Imrich I, Halo M.This study aimed to examine the seasonal dynamics of non-structural carbohydrates in pasture and their relationship to metabolic indicators in horses with a history of laminitis. Thirty Hucul mares were divided into a laminitis group (LG, = 15) and a control group (CG, = 15). Insulin, glucose, fructosamines concentrations and body weight were monitored during four sampling periods (S0-S3), while pasture variables were analyzed during three periods (S1-S3). The concentration of water-soluble carbohydrates was highest in May (126.8 g/kg DM) and measured lower in October (57.9 g/kg DM), while s...
Effects of total parenteral nutrition and electrolyte solutions with or without glutamine on the hormonal profiles of horses subjected to exploratory laparotomy.
Brazilian journal of veterinary medicine    January 14, 2026   Volume 48 e005725 doi: 10.29374/2527-2179.bjvm005725
Ferreira C, Palhares MS, de Melo UP, Leme FOP, Maranhão RPA, Garcia HC, Gheller VA.Starvation and nutritional support clinically influence horses, particularly during the treatment of gastrointestinal diseases and post-surgical recovery. In this study, we aimed to evaluate the effects of different nutritional strategies on the endocrine response of horses subjected to exploratory laparotomy followed by food deprivation. Sixteen healthy adult horses were randomly allocated into four groups (n=4) based on treatments: enteral fluid therapy without (ENTFL) or with glutamine (ENTGL), and parenteral fluid therapy with glucose (PARFL) or total parenteral nutrition with glutamine (P...
Sodium-glucose transporters SGLT1 and SGLT2 in equine renal, hepatic and pancreatic tissue.
BMC veterinary research    December 17, 2025   Volume 22, Issue 1 36 doi: 10.1186/s12917-025-05173-1
Anger-Håål C, Fjordbakk CT, Ekstrand C, Skedsmo FS, Rørtveit R.Insulin dysregulation is a hallmark of equine metabolic syndrome (EMS), and in recent years, pharmacological treatment with sodium-dependent glucose transporter 2 inhibitors (SGLT2i) have shown promise in reducing the risk of hyperinsulinemia-associated laminitis in horses diagnosed with EMS. In humans and laboratory animals, this transporter protein is responsible for the majority of renal tubular glucose reabsorption, however, the presence of this and the related sodium-dependent glucose transporter 1 (SGLT1) have not yet been studied in equine kidneys. Additionally, studies in humans and la...
Intra-articular methylprednisolone acetate does not induce hyperinsulinemia or hyperglycemia in metabolically normal horses.
Journal of the American Veterinary Medical Association    December 10, 2025   Volume 264, Issue 3 326-331 doi: 10.2460/javma.25.08.0566
Page AE, McPeek JL, Carattini S, McGreevy E, Adam E.The goal of this project was to examine the metabolic effects of IA methylprednisolone acetate (MPA) following injection into multiple low-motion joints. Unassigned: Six 3-year-old geldings without pituitary pars intermedia dysfunction or insulin dysregulation were randomly injected with 20 mg of IA MPA/joint (80 mg total; bilateral distal hock joints) or an equal volume of saline. Serial blood samples were collected for resting ACTH, cortisol, insulin, and glucose, as well as insulin and glucose following repeated low-dose oral sugar tests. Treatments were crossed over after a 6-week washout,...
Leucine, pyridoxine and resveratrol supplementation alter metabolic parameters in ponies with equine metabolic syndrome.
Equine veterinary journal    December 8, 2025   doi: 10.1002/evj.70135
Norton EM, Plumb S, Shane D, Smalley L, McKendry K, Scharf B, Zemel M.Supplements claiming to improve metabolic profiles in equine metabolic syndrome (EMS) often lack scientific validation. Objective: To evaluate the effect of a supplement containing leucine, resveratrol and pyridoxine on the metabolic profile in ponies with EMS. Methods: Unmasked randomised, placebo-controlled field trial. Methods: Thirty-eight ponies completed the trial across five farms. Ponies were age and sex matched per farm and randomly assigned to the supplement (n = 20) or placebo group (n = 18) with owners masked to group assignments. Ponies were sampled at days -1/0 (T1), 7/8 ...
Bile acids segregate metabolic syndrome in a cohort of 100 deeply phenotyped horses.
Communications biology    November 27, 2025   Volume 8, Issue 1 1711 doi: 10.1038/s42003-025-09111-7
Donnelly CG, Peng S, Pflieger L, Manfredi J, Coleman M, Rappaport N, Price ND, Finno CJ.Metabolic syndrome (MetS)-encompassing obesity, insulin resistance, dyslipidemia, and hypertension-is prevalent in both humans and horses, offering a unique opportunity to explore shared pathophysiological mechanisms across species in a controlled model organism. In this first report from the Pioneer 100 Horse Health Project (P100HHP), we conducted a longitudinal, multi-omic analysis of 108 deeply phenotyped horses to interrogate individual health trajectories for precision insights into MetS. We identified two primary metabotypes: one characterized by elevated unsaturated triglycerides (TGs) ...
Forage Carbohydrate Profiles and Endocrine Morphometric Interactions in Traditionally Managed Horses from Romania.
Life (Basel, Switzerland)    November 6, 2025   Volume 15, Issue 11 1721 doi: 10.3390/life15111721
Horses maintained under traditional management systems and dependent on natural forages are often exposed to seasonal and compositional variations that can affect metabolic homeostasis. This study examined associations between forage nutrient composition and metabolic-morphometric indicators in horses from four agroecologically distinct regions of northwestern Romania. Eighty-eight horses managed under semi-extensive rural conditions underwent clinical examination, body condition scoring (BCS), cresty neck scoring (CNS), and fasting blood sampling. Forage samples ( = 34) from daily rations wer...
Revitalizing equine metabolism: how SHBG improves mitochondrial function and reduces inflammation.
BMC veterinary research    October 21, 2025   Volume 21, Issue 1 620 doi: 10.1186/s12917-025-05033-y
Bourebaba N, Domagała J, Bourebaba L.Equine metabolic syndrome (EMS) is associated with chronic low-grade inflammation, disruptions in mitochondrial dynamics and function, and an increased risk of developing laminitis. Recent research has highlighted that reduced levels of sex hormone-binding globulin (SHBG) in the bloodstream are linked to higher susceptibility to obesity, insulin resistance, and diabetes, potentially contributing to broader metabolic imbalances. This study aimed to evaluate whether exogenously administered SHBG could protect adipose-derived stem cells from horses affected by EMS (EqASC) against mitochondrial dy...
Abnormal Fetuin-A levels in obese horses are associated with activated TLR4/NF-ƙB/MAPK axis and depleted FBXW7 E3 ubiquitin ligase.
Veterinary research communications    October 16, 2025   Volume 49, Issue 6 354 doi: 10.1007/s11259-025-10926-2
Bourebaba L, Panek M, Piedra LCC, Bourebaba N.Fetuin-A (FetA) is a multifactorial glycoprotein primarily synthesized by the liver with additional expression in adipose tissue, the abundance of which is tightly regulated by the FBXW7 E3 ubiquitin ligase. Recently, FetA has been implicated in the pathogenesis of insulin resistance and associated metabolic failures in humans through its potent and selective inhibition of insulin receptor tyrosine kinase activity, however, no studies have yet directly investigated its role in the development and progression of equine obesity. In this investigation, FetA levels were measured in serum, liver, a...
Effects of the Sodium-Glucose Cotransporter-2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation.
Journal of veterinary internal medicine    October 9, 2025   Volume 39, Issue 6 e70256 doi: 10.1111/jvim.70256
Thane K, Voth R, Klee R, Warnken T, Chukwu V, Frank N.Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Objective: The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Methods: Privately-owned adult horses (n = 37) with laboratory-confirmed ID (low-dose oral sugar test insulin concentration > 75 μIU/mL). Methods: Double-blind randomized placebo-controlled trial. Horses received placebo (n = 19) or velagliflozin 0.3 mg/kg PO q24h (n = 18) for 20 weeks (Study Period 1, SP1) immediately followed by a 20-week ope...
Equine Pituitary Pars Intermedia Dysfunction.
Veterinary sciences    August 20, 2025   Volume 12, Issue 8 780 doi: 10.3390/vetsci12080780
Menzies-Gow NJ.Pituitary pars intermedia dysfunction (PPID) is a common, slowly progressive, neurodegenerative disorder of the older horse. Oxidative damage to the hypothalamic periventricular neurons results in loss of dopaminergic inhibition of the pars intermedia region of the pituitary gland. Consequently, there is increased production of the pro-opiomelanocortin (POMC)-derived hormones normally produced by this region, as well as initial melanocyte hypertrophy and hyperplasia, followed by adenomatous change. Clinical signs that are highly suggestive of the disease are generalised and regional hypertrich...
Investigations on metabolic diseases of horses in Egypt.
Frontiers in veterinary science    August 18, 2025   Volume 12 1591090 doi: 10.3389/fvets.2025.1591090
Aboelmaaty AM, Ahdy AM, El-Khodery S, Elgioushy M.Obesity is a significant risk factor that predisposes horses to laminitis, equine metabolic syndrome, arthritis, heart disease, and respiratory issues. Unassigned: Mares showing overweight or laminitis ( = 30), different BCS ( = 90) weighing 350-550 Kg were subjected to clinical and rump fat assessments. Blood samples were collected to measure circulating estradiol, progesterone, cortisol, insulin, insulin-like growth factor-1 (IGF-1), and leptin. Additionally, glucose, cholesterol, triglycerides, total proteins, albumin, nitric oxide (NO), lactate dehydrogenase (LDH), glutathione redu...
Gestation-Stage Related Changes in the IGF System Components in the Equine Placenta.
Biomolecules    August 6, 2025   Volume 15, Issue 8 1135 doi: 10.3390/biom15081135
Scoggin KE, Adlan F, Fedorka CE, Rakha SI, Stout TAE, Troedsson MHT, Ali HE.The insulin-like growth factor (IGF) system regulates implantation, placental development, and angiogenesis in eutherian mammals. However, little is known about the changes in this system in equine placenta (chorioallantois; CA) and the endometrium (EN) during pregnancy, or the relationship to vascular endothelial growth factor () expression. The current study investigated the expression of the IGF system components, namely the ligands ( and ), their receptors (, , and ), and their binding proteins ( and s) in equine CA at 45 days, 4, 6, 10, and 11 months of gestational age (GA) and immediatel...
Canagliflozin: Pharmacokinetics, tolerability and glucose/insulin effects of supratherapeutic doses in healthy horses.
Veterinary journal (London, England : 1997)    August 5, 2025   Volume 313 106412 doi: 10.1016/j.tvjl.2025.106412
Michanek P, Bröjer J, Lilliehöök I, Fjordbakk C, Erkas M, Löwgren M, Hedeland M, Bergquist J, Ekstrand C.Sodium-glucose co-transporter 2 inhibitors like canagliflozin (CFZ) have shown promise in preventing hyperinsulinemia-associated laminitis in horses, but data on pharmacokinetics, tolerability, and controlled studies are limited. This randomized, open-label, placebo-controlled, crossover study evaluated these aspects of CFZ treatment in eight healthy Standardbred mares. Each horse received single supratherapeutic oral doses of CFZ (1.8 mg/kg or 3.6 mg/kg) and placebo, with a two-week washout between treatments. A graded glucose infusion (GGI) was administered post-treatment to evaluate glu...
Clinical evaluation of the ADVIA Centaur XPT chemiluminescent immunoassay for equine insulin measurement.
Journal of equine veterinary science    July 31, 2025   Volume 152 105661 doi: 10.1016/j.jevs.2025.105661
Rey-Conejo R, Toribio RE, Möller S, Müller E, Fores-Jackson P.Insulin dysregulation is a key component of equine metabolic syndrome and is commonly assessed using basal insulin concentrations. Different analyzers may yield variable insulin results, limiting comparability. Objective: To assess the analytical performance of the ADVIA Centaur XPT chemiluminescent immunoassay (CLIA) for equine insulin measurement and to establish adapted decision thresholds based on comparison with a previously used CLIA method. Methods: Precision, linearity, and dilution recovery were assessed for the ADVIA Centaur XPT. A total of 89 equine serum samples submitted for basal...
Pioglitazone does not adequately control hyperinsulinemia but does increase serum adiponectin concentrations in equids with severe insulin dysregulation.
Journal of the American Veterinary Medical Association    July 30, 2025   Volume 263, Issue 10 1-11 doi: 10.2460/javma.25.04.0269
Lowndes CR, Boyle AG, Kulp J, Stefanovski D, Davis JL, van Eps A.To characterize the effects of pioglitazone (2 mg/kg, PO, either q 24 h [PIO-SID] or q 12 h [PIO-BID]) in equids with severe hyperinsulinemia. Unassigned: 17 client-owned equids with severe resting hyperinsulinemia (> 100 µIU/mL) were assigned to PIO-SID or PIO-BID in a prospective cohort study with rolling enrollment over an 11-month study period (December 13, 2022, to November 17, 2023). Basal insulin, total and high-molecular-weight adiponectin concentrations, and plasma pioglitazone concentrations were measured over 70 days. Oral sugar tests (OSTs) were performed on days 0 and 28. Results...
Plasma Activin A concentrations are not a useful biomarker for detecting insulin dysregulation and predicting laminitis risk in ponies.
Journal of equine veterinary science    July 29, 2025   105660 doi: 10.1016/j.jevs.2025.105660
McGuire CJ, Knowles EJ, Harris PA, Menzies-Gow NJ.Circulating insulin concentrations are used to quantify risk of laminitis in currently non-laminitic ponies. Basal serum activin A (AA) concentration has previously been positively correlated with serum insulin concentrations 60 minutes (T60) following an oral sugar test (OST) in ponies with equine metabolic syndrome. Therefore, circulating AA might be a useful marker for insulin dysregulation (ID) and laminitis risk. Objective: To explore the relationship between circulating AA concentrations at baseline (T0) and T60 in ponies that developed laminitis within six months and non-laminitic ponie...
Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome.
BMC veterinary research    July 2, 2025   Volume 21, Issue 1 425 doi: 10.1186/s12917-025-04879-6
Espinosa-López EM, Ortiz-Guisado B, Diez de Castro E, Durham A, Aguilera-Tejero E, Gómez-Baena G.Equine Metabolic Syndrome (EMS) is a multifactorial endocrine disorder characterized by obesity, insulin dysregulation (ID), and an increase in the risk of laminitis, a painful condition that can lead to euthanasia in severe cases. Diagnosing EMS is challenging and often relies on clinical history including obesity, difficulty in losing weight, and recurring episodes of laminitis. The gold standard for laboratory support of an EMS diagnosis is the identification of ID, with basal insulin being the simplest and most accessible method, especially in a field setting. However, various factors such...
The effects of a long-duration intravenous infusion of detomidine, with and without vatinoxan, on equine energy metabolism and urine composition.
Veterinary anaesthesia and analgesia    July 2, 2025   S1467-2987(25)00142-4 doi: 10.1016/j.vaa.2025.06.011
Jantunen N, Raekallio M, Obrochta B, Tapio H, Gracia Calvo L, Rivera Pöyhönen R, Hagman K, Karikoski N.To assess the effects of a 4 hour detomidine constant rate infusion (CRI) with and without a vatinoxan CRI on energy metabolism and urine composition. Methods: Randomized, blinded, crossover study. Methods: Eight Finnhorses, 587 (550-620) kg [median (range)] and 13 (4-16) years old. Methods: Horses were administered an intravenous (IV) detomidine loading dose (0.01 mg kg) followed by 240 minutes CRI (0.015 mg kg hour) (DET) and the same detomidine protocol combined with an IV vatinoxan loading dose (0.15 mg kg) and CRI (0.05 mg kg hour) (DET+VAT). Blood samples for glucose, insulin, non-esteri...
Identifying insulinemic responses of ID horses offered varying levels of NSC and meal-sizes.
Journal of equine veterinary science    June 29, 2025   Volume 151 105638 doi: 10.1016/j.jevs.2025.105638
Kerley BS, Harris P, Jacquay E, Askins M, McClendon M, Adams AA.Feeding small meals (∼1 g/kg BW DM basis) providing >10% nonstructural carbohydrates (NSC; starch + water soluble carbohydrate; WSC) has resulted in an augmented insulin response (AIR) in insulin dysregulated (ID) horses, but it's unclear if AIR reflects NSC content or the g NSC/kg BW/meal. Objective: The insulinemic responses of ID (n = 7) and non-insulin dysregulated (NID; n = 8) horses fed four feeds (A = 6.8% NSC; B = 14.9% NSC; C = 35.5% NSC; D = 44.6% NSC) at three levels of NSC intake (0.06, 0.11-0.12 and 0.17-0.18 g/kg BW) were evaluated in a randomized Latin square design across two...
Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses.
Journal of veterinary internal medicine    June 6, 2025   Volume 39, Issue 4 e70143 doi: 10.1111/jvim.70143
Dosi M, Scott L, Payne H, Poldy J, Keen J, McGorum B, Malbon A, Morgan R.Hyperinsulinaemia (HI) is an important feature of Equine Metabolic Syndrome (EMS). It has been suggested that reduced hepatic clearance of insulin contributes to HI, particularly in humans affected by metabolic dysfunction-associated steatotic liver disease (MASLD). Objective: In obese horses with HI, insulin clearance is impaired and associated with MASLD. Methods: Tissue samples were collected at post-mortem from clinically well-characterized horses with HI (n = 13; basal insulin > 20 mIU/l) and without HI (control; n = 20). Methods: Retrospective observational study. Molecular d...
Prevalence and Progression of Resting ACTH, Insulin and Adiponectin Values as Indicators of Suspected Endocrine Diseases in Sport Horses and Ponies Compared to Non-Sport Horses, Ponies and Donkeys.
Animals : an open access journal from MDPI    May 1, 2025   Volume 15, Issue 9 1316 doi: 10.3390/ani15091316
Davis EL, Wood AD, Potier JFN.Prevalence of endocrine disease in sport horses has been sparsely reported. They often compete well into their teenage years; thus, diagnosis and control of endocrine disease could be important to maintain performance and optimise health and welfare. The aim was to compare the prevalence of pituitary pars intermedia dysfunction (PPID), insulin dysregulation (ID) and metabolic obesity between sport and non-sport type breeds and assess disease progression. Blood samples submitted for plasma adrenocorticotropic hormone (ACTH), serum insulin or adiponectin were included in this study. Horses were ...
1 2 3 30